FreeAgent 4f7a5d374bf3a9d10e28d39f49b158bb75c384b1 false No description of principal activity 13 January 2025 31 January 2026 161815812025-01-132026-01-31 16181581uk-bus:Director12025-01-132026-01-31 16181581uk-bus:AuditExempt-NoAccountantsReport2025-01-132026-01-31 16181581uk-bus:Micro-entities2025-01-132026-01-31 16181581uk-bus:FullAccounts2025-01-132026-01-31 16181581uk-bus:PrivateLimitedCompanyLtd2025-01-132026-01-31 16181581uk-bus:RegisteredOfficeuk-countries:UnitedKingdom2025-01-132026-01-31 161815812025-01-13 161815812026-01-31 16181581uk-core:CurrentFinancialInstruments2026-01-31 16181581uk-core:Non-currentFinancialInstruments2026-01-31 iso4217:GBP xbrli:pure

Prestige Pharma Limited

Unaudited financial statements for the period from 13 January 2025 to 31 January 2026


Company information

Prestige Pharma Limited is a private company limited by shares, registered in England and Wales, registered number 16181581.

The company's registered office is: 7 Loveridge Drive, Alphington, Exeter, EX2 0AD, United Kingdom.

Balance Sheet

as at 31 January 2026

13 months to
31 Jan 26
£ £
Current assets 48,407.91
Creditors: amounts falling due within one year (15,925.20)
Net current assets / (liabilities) 32,482.71
Total assets less current liabilities 32,482.71
Accruals and deferred income (32,380.00)
Net assets 102.71
Capital and reserves 102.71

For the period from 13 January 2025 to 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Directors' responsibilities:

Approved by the board of directors and signed on behalf of the board,

Clement Tan
13 October 2026

Notes to the accounts

  1. Average number of employees

    During the period the average number of employees was 1.